KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,655,030 | +47.6% | 86,670 | +89.3% | 0.01% | +50.0% |
Q2 2023 | $9,929,561 | -71.4% | 45,790 | -83.3% | 0.01% | -69.2% |
Q1 2022 | $34,682,000 | +46.9% | 273,540 | +51.8% | 0.03% | +73.3% |
Q4 2021 | $23,613,000 | +118.5% | 180,250 | +104.0% | 0.02% | +114.3% |
Q3 2021 | $10,807,000 | – | 88,341 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |